Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 7, 2005; 11(25): 3855-3859
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3855
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3855
Table 1 Relationship of the expression of survivin and clinicopatho-logical factors of HCC
| n | Survivin | P | ||
| Positive (n) | Percent (%) | |||
| Tissue | < 0.01 | |||
| Cirrhosis | 38 | 3 | 7.9 | |
| HCC | 38 | 23 | 60.5 | |
| Age (yr) | > 0.05 | |||
| < 60 | 31 | 19 | 61.3 | |
| ≥ 60 | 7 | 4 | 57.1 | |
| Sex | > 0.05 | |||
| Male | 33 | 21 | 63.6 | |
| Female | 5 | 2 | 40 | |
| Size (cm) | > 0.05 | |||
| ≥ 5 | 17 | 12 | 70.6 | |
| < 5 | 21 | 11 | 52.4 | |
| Differentiation | > 0.05 | |||
| Moderate to well | 16 | 9 | 56.3 | |
| Poor | 22 | 14 | 63.6 | |
| Metastasis | < 0.05 | |||
| Positive | 14 | 12 | 85.7 | |
| Negative | 24 | 11 | 45.8 | |
- Citation: Zhu H, Chen XP, Zhang WG, Luo SF, Zhang BX. Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. World J Gastroenterol 2005; 11(25): 3855-3859
- URL: https://www.wjgnet.com/1007-9327/full/v11/i25/3855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i25.3855